Gemcitabine Pancreatic Cancer
Dec. 26, 2024
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going | Experimental & Molecular Medicine LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes | Molecular Cancer | Full Text IJMS | Free Full-Text | Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer Gemcitabine Pancreatic Cancer
![PDF] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with ad…](https://d3i71xaburhd42.cloudfront.net/1a6ab5ded3face432eed101b9a694517562403bb/4-Figure1-1.png){kind=link}
![GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/12728/1/fig-2-2x.jpg){kind=link}
![PDF] FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. | Semantic Sch…](https://d3i71xaburhd42.cloudfront.net/11e708851d64ab23f0cfec1c88af6f0d9e466a57/6-Figure1-1.png){kind=link}
![PDF] Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemci…](https://d3i71xaburhd42.cloudfront.net/c6b29cfeb8755c10c38ac14694c570f613d909f5/10-Figure2-1.png){kind=link}
